Group-based Comprehensive Lifestyle Program for Women With Metastatic Breast Cancer
Part of paid clinical trials in Houston, Texas.
- Sponsor
- M.D. Anderson Cancer Center
- Study ID
- NCT07179809
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Demographics/Lifestyle Survey — OTHERParticipants will complete all sessions and instruments
Study Details
The research study is to learn how the ACLP can best support patients with stable HR+/HER2- MBC.
Key Dates
- Start date
- Feb 28, 2026
- Status verified
- Sep 2025
- Primary completion
- Oct 1, 2027
- Completion
- Oct 1, 2029
Study Design
- Enrollment
- 100 participants (estimated)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: ACLP ProgramParticipants will take part in the ACLP alone
- Experimental: ACLP Program + Learning CirclesParticipants will take part in the ACLP and Learning Circles
- Experimental: ACLP Program + Learning Circles + Individual Health CoachingParticipants will take part in the ACLP and in Learning Circles After participants complete the ACLP with Learning Circles, they will receive up to 6 individualized health coaching sessions.
Primary Outcome Measure
Safety and Adverse Events (AEs) [ Time Frame: Through study completion; an average of 1 year. ]
Central Contacts
- Meroe Morse, MD713-794-4053
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| The University of Texas M. D. Anderson Cancer Center | Houston | Texas | 77030 | Meroe Morse, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Houston, TX
By condition
By specialty
Related Studies
- A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerPHASE1/PHASE2 · Recruiting · Hoffmann-La Roche · Duarte, California
- Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast CancerPHASE1/PHASE2 · Recruiting · Phoenix Molecular Designs · Gilbert, Arizona
- A Study of BTX-A51 in People With Advanced Solid Tumor and Breast CancerPHASE1 · Recruiting · Edgewood Oncology Inc. · Lake Mary, Florida
- CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast CancerPHASE1 · Recruiting · University of Texas Southwestern Medical Center · Chicago, Illinois